Breakthrough gene therapy company snared by Japanese biopharma for $3 billion
December 03, 2019 at 09:37 AM EST
Audentes has been a pioneer in one-shot-and-you're-done gene therapy field.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.